Securities Code: 300869
Securities Abbreviation: Kangtai Medical
Announcement Number: 2026-005
Bond Code: 123151
Bond Abbreviation: Kangyi Convertible Bond
Kangtai Medical Systems (Qinhuangdao) Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
On February 26, 2026, the Company held the 25th meeting of the 4th Board of Directors, where it reviewed and approved the proposal on the use of idle self-owned funds for cash management. The Company plans to use a total amount not exceeding RMB 200 million (including the principal) of idle self-owned funds for cash management, ensuring that it does not affect normal operations and fund safety. This amount is valid for 12 months from the date of approval by the Board of Directors, and the funds can be used in a rolling manner within the aforementioned limit and timeframe. This cash management initiative falls within the approval authority of the Company's Board of Directors and does not require submission to the shareholders' meeting for review. This investment does not constitute a related party transaction and does not constitute a major asset reorganization as defined by the "Administrative Measures for Major Asset Restructuring of Listed Companies." The specific circumstances are announced as follows: